ZetrOZ, Inc.

Free public records show ZetrOZ, Inc. in 2 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by ZetrOZ, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on ZetrOZ, Inc.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

US device clearances

5 510(k) clearances and PMA approvals since 2015

Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.

See them on openFDA (opens in a new tab)

Trials over time

Studies ZetrOZ, Inc. leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with ZetrOZ, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show ZetrOZ, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Healthcare Topics

The topics of the markets ZetrOZ, Inc. is in.

All healthcare topics

Search all reports for ZetrOZ, Inc. All companies